VENTAS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.1 USD | -0.41% |
|
+1.65% | -11.16% |
| 12:05pm | Morning Bid: Mayday for bonds as 2024 Fed cut hopes dwindle | RE |
| Apr. 29 | Evercore ISI Adjusts Price Target on Ventas to $49 From $50 | MT |
Financials (USD)
| Sales 2024 * | 4.8B | Sales 2025 * | 5.07B | Capitalization | 17.83B |
|---|---|---|---|---|---|
| Net income 2024 * | -534M | Net income 2025 * | -260M | EV / Sales 2024 * | 6.46 x |
| Net Debt 2024 * | 13.21B | Net Debt 2025 * | 13.23B | EV / Sales 2025 * | 6.12 x |
| P/E ratio 2024 * |
-34.3
x | P/E ratio 2025 * |
-57.1
x | Employees | 486 |
| Yield 2024 * |
4.17% | Yield 2025 * |
4.35% | Free-Float | 99.35% |
More Fundamentals
* Assessed data
More news
Latest transcript on Ventas, Inc.
More recommendations
More press releases
More news
| 1 day | -0.87% | ||
| 1 week | +1.65% | ||
| 1 month | +1.70% | ||
| 3 months | -4.55% | ||
| 6 months | +4.29% | ||
| Current year | -11.16% |
1 week
43.11
45.17
1 month
41.4545.17
Current year
41.4550.61
1 year
39.3350.99
3 years
35.3364.02
5 years
13.3575.40
10 years
13.3581.93
| Managers | Title | Age | Since |
|---|---|---|---|
Debra Cafaro
CEO | Chief Executive Officer | 66 | 98-12-31 |
Bob Probst
DFI | Director of Finance/CFO | 56 | 14-10-26 |
| Chief Tech/Sci/R&D Officer | - | 19-01-24 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Michael Embler
BRD | Director/Board Member | 59 | 22-03-06 |
Matthew Lustig
BRD | Director/Board Member | 63 | 11-05-11 |
Marguerite Nader
BRD | Director/Board Member | 55 | 20-07-05 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.03% | 208 M€ | -.--% | ||
| 1.91% | 285 M€ | -3.73% | ||
| 1.43% | 130 M€ | +1.42% | ||
| 0.99% | 0 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-30 | 44.28 | -0.87% | 2 740 830 |
| 24-04-29 | 44.67 | +1.52% | 1,919,631 |
| 24-04-26 | 44 | +1.48% | 1,899,133 |
| 24-04-25 | 43.36 | -0.57% | 1,162,358 |
| 24-04-24 | 43.61 | +0.11% | 1,490,803 |
Delayed Quote Nyse, April 30, 2024 at 04:00 pm EDT
More quotes
Ventas, Inc. specializes in owning and managing healthcare and medical-residential facilities.
At the end of 2022, the group's portfolio included 1,237 assets consisting primarily of senior housing (802), medical office buildings (313), rehabilitation and long-term acute care facilities (36), laboratories and research facilities (32), skilled nursing facilities (16), medical and surgical facilities (13).
Net sales are distributed geographically as follows: the United States (88.5%), Canada (10.9%) and the United Kingdom (0.6%).
Sector
Specialized REITs
Calendar
2024-04-30
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
44.28
USD
Average target price
52.42
USD
Spread / Average Target
+18.39%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -11.16% | 17.83B | |
| +5.67% | 56.3B | |
| -6.01% | 13.1B | |
| -0.82% | 7.51B | |
| -17.41% | 5.43B | |
| +10.46% | 3.34B | |
| -2.45% | 3.22B | |
| -5.50% | 3.06B | |
| -6.31% | 2.79B | |
| +12.91% | 2.74B |
- Stock Market
- Equities
- VTR Stock
